Martin Abraham Guiloff Salvador of Rani Therapeutics Holdings sold a total of 5,923,000 shares.

Filings Track

Oct 23

Martin Abraham Guiloff Salvador, a director of Rani Therapeutics Holdings, sold 1,923,000 and 4,000,000 shares of common stock on October 20 and October 21, 2025, respectively. Following these transactions, the total beneficially owned shares amount to 2,379,194. This significant disposal could signal concerns about the company's future prospects, warranting investor attention to market reactions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1151619735"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151619735\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151619735?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-23 07:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151619735","market":"us","top_or_hot":-1,"title":"Martin Abraham Guiloff Salvador of Rani Therapeutics Holdings sold a total of 5,923,000 shares.","media":"Filings Track","content":"Martin Abraham Guiloff Salvador, a director of Rani Therapeutics Holdings, sold 1,923,000 and 4,000,000 shares of common stock on October 20 and October 21, 2025, respectively. Following these transactions, the total beneficially owned shares amount to 2,379,194. This significant disposal could signal concerns about the company's future prospects, warranting investor attention to market reactions.","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Martin Abraham Guiloff Salvador of Rani Therapeutics Holdings sold a total of 5,923,000 shares.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMartin Abraham Guiloff Salvador of Rani Therapeutics Holdings sold a total of 5,923,000 shares.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1033292654\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/f241068b466f5f9316243a75366834d5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Filings Track </p>\n<p class=\"h-time\">2025-10-23 07:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\nMartin Abraham Guiloff Salvador, a director of Rani Therapeutics Holdings, sold 1,923,000 and 4,000,000 shares of common stock on October 20 and October 21, 2025, respectively. Following these transactions, the total beneficially owned shares amount to 2,379,194. This significant disposal could signal concerns about the company's future prospects, warranting investor attention to market reactions.\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RANI","symbol_name":"Rani Therapeutics Holdings","start_time":0,"source_url":"","article_id":"1151619735","we_media_id":"1033292654","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151619735","pubTimestamp":1761174013,"columns":[{"name":"Insider Trades","id":28,"label_key":"insiderTrades"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Filings Track","introduction":"Stay Updated with Major Exchanges' Announcements","home_visible":1,"id":"1033292654","head_image":"https://static.tigerbbs.com/f241068b466f5f9316243a75366834d5"},"summary":"Martin Abraham Guiloff Salvador, a director of Rani Therapeutics Holdings, sold 1,923,000 and 4,000,000 shares of common stock on October 20 and October 21, 2025, respectively. Following these...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RANI":"Rani Therapeutics Holdings"},"translate_title":"Rani Therapeutics Holdings的Martin Abraham Guiloff Salvador总共出售了5,923,000股股票。","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RANI":1},"content_text":"Martin Abraham Guiloff Salvador, a director of Rani Therapeutics Holdings, sold 1,923,000 and 4,000,000 shares of common stock on October 20 and October 21, 2025, respectively. Following these transactions, the total beneficially owned shares amount to 2,379,194. This significant disposal could signal concerns about the company's future prospects, warranting investor attention to market reactions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"insiderTrades","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}